McCormick, Liam M <br/><br/>
Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.  [electronic resource] 

 -  Cardiovascular diabetology  Aug 2015 
 - 102 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1475-2840 
<br/><br/><label>Standard No.: </label>10.1186/s12933-015-0259-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Biomarkers--blood<br/>Biomechanical Phenomena<br/>Blood Glucose--drug effects<br/>Coronary Artery Disease--complications<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Cardiomyopathies--diagnosis<br/>Echocardiography, Doppler, Color<br/>Echocardiography, Stress<br/>Female<br/>Glucagon-Like Peptide 1--administration & dosage<br/>Glucose Clamp Technique<br/>Humans<br/>Hyperglycemia--blood<br/>Incretins--administration & dosage<br/>Infusions, Intravenous<br/>Insulin--blood<br/>Male<br/>Middle Aged<br/>Myocardial Contraction--drug effects<br/>Peptide Fragments--administration & dosage<br/>Stroke Volume--drug effects<br/>Ventricular Dysfunction, Left--diagnosis<br/>Ventricular Function, Left--drug effects